Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeuroDx Development
Yardley, Pennsylvania, USAneurodx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
NeuroDx Development is a clinical-stage medical device company focused on non-invasive diagnostic devices for the neurosurgery market. Its lead product, ShuntCheck, is FDA-cleared and used to assess cerebrospinal fluid shunt function in hydrocephalus patients. The company is also developing ICPCheck, a non-invasive monitor for elevated intracranial pressure. Clinical studies have demonstrated the utility of ShuntCheck in pediatric populations, offering a safer alternative to CT scans or invasive procedures[1][2].
- Therapeutic areas
- Neurology
- Modalities
- DeviceDiagnostic device (non-invasive)
- Industry
- Physiological Monitoring
Beyond the preview
Go deeper on NeuroDx Development.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NeuroDx Development.